High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples